← Back to Clinical Trials
Recruiting NCT07231913

NCT07231913 Emotional Awareness and Communication Training Effectiveness in Oncology Nurses

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07231913
Status Recruiting
Phase
Sponsor Ankara Yildirim Beyazıt University
Condition Occupational Burnout
Study Type INTERVENTIONAL
Enrollment 64 participants
Start Date 2025-10-25
Primary Completion 2026-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Structured Emotional Awareness and Communication TrainingEducational Materials

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 64 participants in total. It began in 2025-10-25 with a primary completion date of 2026-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This interventional clinical study aims to evaluate whether a structured emotional awareness and communication training program can reduce occupational burnout among oncology nurses. The study will address the following primary questions: Does the intervention lead to a significant increase in nurses' emotional awareness? Does it improve their communication skills in challenging patient and family interactions? Does it reduce their levels of professional burnout? Participants will be recruited from oncology nurses working at Ankara Etlik City Hospital who have been employed in the unit for at least six months and consent to participate. A total of 64 nurses will be randomly assigned to an intervention group (n=32), receiving four weekly face-to-face training sessions over four weeks, or a control group (n=32), receiving educational materials in written/digital format. Data will be collected using pre- and post-intervention assessments with the Maslach Burnout Inventory, the Emotional Requirements Scale, and the Communication Skills Scale for Healthcare Professionals. All data will be anonymized and analyzed to determine the effectiveness of the intervention in enhancing emotional awareness and communication skills and in reducing burnout among oncology nurses.

Eligibility Criteria

Inclusion Criteria: * Employed as a nurse in an oncology unit for at least 6 months * Voluntarily agrees to participate in the study * Able to attend all training sessions * Completes both pre-test and post-test questionnaires Exclusion Criteria: * Currently on leave or planning to take leave during the study period * Has received prior structured training related to emotional awareness or communication skills within the past year * Diagnosed with a severe psychological disorder that may affect participation

Contact & Investigator

Central Contact

Elif Çırpanlı, MSc Student (Nursing)

✉ elifcirpanli@gmail.com

📞 +905511446486

Frequently Asked Questions

Who can join the NCT07231913 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Occupational Burnout. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07231913 currently recruiting?

Yes, NCT07231913 is actively recruiting participants. Contact the research team at elifcirpanli@gmail.com for enrollment information.

Where is the NCT07231913 trial being conducted?

This trial is being conducted at Ankara, Turkey (Türkiye).

Who is sponsoring the NCT07231913 clinical trial?

NCT07231913 is sponsored by Ankara Yildirim Beyazıt University. The trial plans to enroll 64 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology